QIAGEN Operating Income 2010-2023 | QGEN
QIAGEN annual/quarterly operating income history and growth rate from 2010 to 2023. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
- QIAGEN operating income for the quarter ending March 31, 2023 was $0.097B, a 53.3% decline year-over-year.
- QIAGEN operating income for the twelve months ending March 31, 2023 was $0.421B, a 37.46% decline year-over-year.
- QIAGEN annual operating income for 2022 was $0.531B, a 15.65% decline from 2021.
- QIAGEN annual operating income for 2021 was $0.63B, a 63.05% increase from 2020.
- QIAGEN annual operating income for 2020 was $0.386B, a 1578.54% decline from 2019.
QIAGEN Annual Operating Income
(Millions of US $) |
| 2022 |
$531 |
| 2021 |
$630 |
| 2020 |
$386 |
| 2019 |
$-26 |
| 2018 |
$267 |
| 2017 |
$153 |
| 2016 |
$99 |
| 2015 |
$179 |
| 2014 |
$162 |
| 2013 |
$63 |
| 2012 |
$170 |
| 2011 |
$100 |
| 2010 |
$189 |
| 2009 |
$180 |
QIAGEN Quarterly Operating Income
(Millions of US $) |
| 2023-03-31 |
$97 |
| 2022-12-31 |
$105 |
| 2022-09-30 |
$98 |
| 2022-06-30 |
$122 |
| 2022-03-31 |
$207 |
| 2021-12-31 |
$173 |
| 2021-09-30 |
$132 |
| 2021-06-30 |
$161 |
| 2021-03-31 |
$164 |
| 2020-12-31 |
$156 |
| 2020-09-30 |
$45 |
| 2020-06-30 |
$119 |
| 2020-03-31 |
$67 |
| 2019-12-31 |
$80 |
| 2019-09-30 |
$-207 |
| 2019-06-30 |
$60 |
| 2019-03-31 |
$41 |
| 2018-12-31 |
$88 |
| 2018-09-30 |
$77 |
| 2018-06-30 |
$53 |
| 2018-03-31 |
$48 |
| 2017-12-31 |
$43 |
| 2017-09-30 |
$64 |
| 2017-06-30 |
$22 |
| 2017-03-31 |
$24 |
| 2016-12-31 |
$4 |
| 2016-09-30 |
$48 |
| 2016-06-30 |
$30 |
| 2016-03-31 |
$17 |
| 2015-12-31 |
$58 |
| 2015-09-30 |
$46 |
| 2015-06-30 |
$40 |
| 2015-03-31 |
$35 |
| 2014-12-31 |
$21 |
| 2014-09-30 |
$50 |
| 2014-06-30 |
$48 |
| 2014-03-31 |
$42 |
| 2013-12-31 |
$34 |
| 2013-09-30 |
$34 |
| 2013-06-30 |
$-34 |
| 2013-03-31 |
$29 |
| 2012-12-31 |
$49 |
| 2012-09-30 |
$39 |
| 2012-06-30 |
$45 |
| 2012-03-31 |
$36 |
| 2011-12-31 |
$-20 |
| 2011-09-30 |
$34 |
| 2011-06-30 |
$46 |
| 2011-03-31 |
$38 |
| 2010-12-31 |
$51 |
| 2010-09-30 |
$50 |
| 2010-06-30 |
$43 |
| 2010-03-31 |
$45 |
| 2009-12-31 |
$35 |
| 2009-09-30 |
$53 |
| 2009-06-30 |
$51 |
| 2009-03-31 |
$41 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$10.584B |
$2.142B |
|
QIAGEN N.V. is one of the world's leading providers of technologies and products for the separation, purification and handling of nucleic acids DNA/RNA. The company provides innovative technologies and products for pre-analytical sample preparation and molecular diagnostics solutions. It has developed a comprehensive portfolio of proprietary, consumable products, and automated solutions for sample collection. Qiagen has subsidiaries several other countries with good sales potential. Segment Details Consumables: These are typically sample preparation or test kits that contain all the necessary reagents and buffers, and a manual including protocols and relevant background information. Automated Instruments: These automate the use of Sample & Assay Technologies into efficient solutions for a broad range of laboratory needs. Customer Classes: QIAGEN focuses on 4 principal segments or customer classes for sample and assay technologies:? Molecular Diagnostics, Applied Testing, Pharma and Academia.
|
